Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-004629
Filing Date
2017-05-15
Accepted
2017-05-12 21:40:16
Documents
60
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q innv10q_mar312017.htm 10-Q 949409
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 17466
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 17281
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 9388
  Complete submission text file 0001654954-17-004629.txt   3676397

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT innv-20170331.xml EX-101.INS 552824
6 XBRL TAXONOMY EXTENSION SCHEMA innv-20170331.xsd EX-101.SCH 48689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20170331_cal.xml EX-101.CAL 50127
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20170331_def.xml EX-101.DEF 119271
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20170331_lab.xml EX-101.LAB 301647
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20170331_pre.xml EX-101.PRE 224095
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 17840761
SIC: 2834 Pharmaceutical Preparations